Filing Details

Accession Number:
0001055726-21-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-03 19:12:42
Reporting Period:
2021-02-01
Accepted Time:
2021-02-03 19:12:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330969592
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1771498 Elizabeth Jacqueline Shea 660 W. Germantown Pike
Plymouth Meeting PA 19462
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-01 22,376 $3.62 66,871 No 4 M Direct
Common Stock Disposition 2021-02-01 22,376 $15.06 44,495 No 4 S Direct
Common Stock Disposition 2021-02-01 5,960 $15.00 38,535 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option Disposition 2021-02-01 22,376 $0.00 22,376 $3.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2019-03-25 2029-03-25 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. These transactions were executed in multiple trades at prices ranging from $15.00 to $15.32, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. These transactions were executed in multiple trades at prices ranging from $15.00 to $15.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.